Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 442 results for "zydus cadila"

Zydus Cadila and Takeda partner to develop vaccine for Chikungunya virus
Pharmaceutical Technology

Zydus and Takeda collaborates for chikungunya vaccine

Share Tweet Share Share Share Zydus Cadila and Takeda Pharmaceutical have entered into partnership to develop the first vaccine to treat chikungunya virus infection. The broad-based agreement includes early stage development ... EHealth Magazine, 1 month ago

49 images for zydus cadila, 3 weeks ago
Money Today, 1 month ago
Indiatimes, 1 week ago
Financial Express, 1 month ago
Indian Express, 1 month ago
DNA, 3 weeks ago
Silicon India, 1 month ago, 1 month ago
Pharmaceutical Technology, 1 month ago
DNA, 1 month ago
Money Control

Zydus ties up with Medicines for Malaria Venture to co-develop antimalarial drug

New Delhi: The Ahmedabad-based Zydus Cadila will tie-up with Medicines for Malaria Ventures (MMV) to develop the investigational antimalarial compound, MMV674253, which was discovered by MMV in collaboration with AstraZeneca, India. Zydus will lead ...
 India Brand Equity Foundation3 weeks ago Zydus partners Swiss non-profit for malaria drug development  Economic Times3 weeks ago Zydus Cadila and MMV partner to develop new antimalarial drug  PharmaBiz3 weeks ago Zydus Cadila inks pact with Medicines for Malaria Venture  Business Line3 weeks ago
Money Control

Zydus Group Clinches Deal With Switzerland-Based Neovii

Cadila Healthcare said Grafalon offers a specific advantage of efficacy and better safety profile through targeted immunosuppression. Cadila Healthcare stock ended 0.36% lower on Thursday. New Delhi : Ahmedabad-based Zydus Group ...
 NDTV2 weeks ago BRIEF-Zydus signs in-licensing deal with Neovii of Switzerland  Reuters UK2 weeks ago Zydus enters into in-licensing deal with Neovii  Hindu Business Line2 weeks ago Zydus Group clinches in-licensing deal with Swiss co Neovii  Money Control2 weeks ago
India Infoline

Zydus, Takeda partner to develop & market chikungunya vaccine

Zydus Cadila, an innovation driven global healthcare provider and Takeda Pharmaceutical Company Limited, (Takeda), announced a partnership to tackle chikungunya, an emerging infectious disease. The chikungunya virus is most often spread to people by ...
 PharmaBiz1 month ago Zydus Cadila enters into partnership with Takeda  HT Syndication1 month ago Zydus and Takeda enter into partnership to address emerging infectious diseases  India Infoline1 month ago Zydus & Takeda partner to address emerging infectious disease  Pharma Business International1 month ago

Pfizer launches legal action to block Xeljanz copies in India

Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts to copy its rheumatoid arthritis (RA) treatment Xeljanz. The US pharma firm filed a case last month against Sun ...
 Pharmafile1 month ago Court battle over Zydus Cadila's breast cancer drug continues  Economic Times1 month ago Court defers decision on Roche's plea against Zydus' cancer drug  Economic Times2 months ago Now, Roche takes Zydus Cadila to court over breast cancer drug  Economic Times2 months ago

Zydus Cadila, Takeda to co-develop vaccine for chikungunya

Singapore: Japan's Takeda pharmaceuticals has joined hands with India-based Zydus Cadila in an aim to co-develop a vaccine for chikungunya. As per the terms the companies will jointly develop the vaccine right from the early-stage development to its ...
 CPhI.cn4 weeks ago
Financial Express

Zydus Recalls 14,800 Bottles Of Bromocriptine Mesylate Capsules

New Delhi : Zydus Cadila is recalling over14,800 bottles of Bromocriptine Mesylate capsules manufacturedby Cadila Healthcare on account of out of specificationresults. According to information available on the USFood and Drug Administration (FDA) ...
 NDTV1 month ago

Zydus recalls over 2lakh bottles of anti-depressant drug in US

Zydus Cadila is recalling over 2 lakh bottles of anti-depressant Venlafaxine HCL ER capsules in the US in two different strengths for failed dissolution specifications. According to information available on the United States Food and Drug ...
 Business Standard2 months ago Zydus Recalls Over Two Lakh Bottles Of Anti-Depressant Drug In US  NDTV Profit2 months ago Zydus Cadila recalls over 2lakh bottles of anti-depressant drug in US  Financial Express2 months ago Zydus recalls over 2 lakh bottles of anti-depressant drug in US  Money Control2 months ago
Money Control

Cadila Healthcare ends in red; acquires derma brand of Issar Pharma

The Zydus Group, an innovation-led global healthcare provider announced that it has acquired Melgain from Hyderabad based Issar Pharma.
 India Infoline2 months ago Zydus acquires skin treatment lotion Melgain from Issar Pharma  Money Control2 months ago Cadila buys skin treatment lotion Melgain from Issar Pharma  Business Line2 months ago
Silicon India

Zydus Cadila in Association with Japan's Takeda Pharma to Develop Chikungunya Vaccine

Zydus Cadila joins hand with Japan's Takeda Pharmaceutical to prepare vaccine that will provide immunity against chikungunya. The contract between the companies includes developing the vaccine from the scratch till the final commercialization of the vaccine.
 Silicon India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
Get updated on latest news & your favorite topics right in your inbox!
More     Less